253 related articles for article (PubMed ID: 12115245)
1. Protoporphyrin IX photodynamic therapy for synovitis.
Kirdaite G; Lange N; Busso N; Van Den Bergh H; Kucera P; So A
Arthritis Rheum; 2002 May; 46(5):1371-8. PubMed ID: 12115245
[TBL] [Abstract][Full Text] [Related]
2. In vitro resistance of articular chondrocytes to 5-Aminolevulinic acid based photodynamic therapy.
Egli RJ; Di Criscio A; Hempfing A; Schoeniger R; Ganz R; Hofstetter W; Leunig M
Lasers Surg Med; 2008 Apr; 40(4):282-90. PubMed ID: 18412230
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic effects of 5-aminolevulinic acid and its hexylester on several cell lines.
Wu SM; Ren QG; Zhou MO; Wei Y; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):655-60. PubMed ID: 12883637
[TBL] [Abstract][Full Text] [Related]
5. Induction of protoporphyrin IX in patient-derived synoviocytes, cartilage explants and chondrons after application of 5-aminolevulinic acid or its methyl ester.
Rudys R; Denkovskij J; Kirdaitė G; Bagdonas S
J Photochem Photobiol B; 2014 Dec; 141():228-34. PubMed ID: 25463671
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence detection and depletion of T47D breast cancer cells from human mononuclear cell-enriched blood preparations by photodynamic treatment: Basic in vitro experiments towards the removal of circulating tumor cells.
Ziegler VG; Knaup J; Stahl D; Krammer B; Plaetzer K
Lasers Surg Med; 2011 Sep; 43(7):548-56. PubMed ID: 22057482
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
9. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo.
Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE
Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy (PDT) - Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines.
Wu RW; Yow CM; Wong CK; Lam YH
Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):254-63. PubMed ID: 21864799
[TBL] [Abstract][Full Text] [Related]
12. Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.
Yang X; Palasuberniam P; Myers KA; Wang C; Chen B
Oncotarget; 2016 Sep; 7(36):57798-57810. PubMed ID: 27527860
[TBL] [Abstract][Full Text] [Related]
13. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
Magnussen A; Reburn C; Perry A; Wood M; Curnow A
Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment.
Ross EV; Romero R; Kollias N; Crum C; Anderson RR
Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233
[TBL] [Abstract][Full Text] [Related]
15. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
Blake E; Allen J; Curnow A
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
Kleemann D; MacRobert AJ; Mentzel T; Speight PM; Bown SG
Br J Cancer; 1996 Jul; 74(1):49-58. PubMed ID: 8679457
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of protoporphyrin-IX in rat Leydig cells following induction by 5-aminolevulinic acid and tramadol.
Wołuń-Cholewa M; Butowska W; Warchoł W
Photomed Laser Surg; 2007 Dec; 25(6):526-9. PubMed ID: 18158756
[TBL] [Abstract][Full Text] [Related]
18. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
19. Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells.
Hefti M; Albert I; Luginbuehl V
J Neurooncol; 2012 Jul; 108(3):443-50. PubMed ID: 22528787
[TBL] [Abstract][Full Text] [Related]
20. [5-Aminolevulinic acid esters based photodynamic therapy].
Zhang S; Zhang Z; Jiang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
